statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

PARIS and CAMBRIDGE, Mass., March 06, 2024 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO NASDAQ: NBTX the ''Company''), a late-clinical stage biotechnology company pioneering physics-based...

Nanobiotix to Present at Upcoming Investor Conferences in March

For the last three days, A.I.dvisor has detected that NBTX's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...

Nanobiotix SA (NBTX, $7) Aroon Indicator entered a Downtrend on February 23, 2024.

Nanobiotix SA (NBTX, $7) Aroon Indicator entered a Downtrend on February 22, 2024.

This is a signal that NBTX's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...

Nanobiotix SA (NBTX, $7) RSI Indicator left the oversold zone on February 22, 2024

Nanobiotix SA (NBTX, $6.3) RSI Indicator left the oversold zone on February 21, 2024

This indicator may be signaling that NBTX's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...

Nanobiotix SA (NBTX, $6.35) entered Downtrend as Momentum indicator drops below 0 level on Feb 20, 2024

In trading on Tuesday, shares of Nanobiotix SA (NBTX) crossed below their 200 day moving average of 6.88, changing hands as low as 6.23 per share. Nanobiotix SA shares are currently...

Notable Two Hundred Day Moving Average Cross - NBTX

PARIS and CAMBRIDGE, Mass., Jan. 31, 2024 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO NASDAQ: NBTX the ''Company''), a late-clinical stage biotechnology company pioneering physics-based...

Nanobiotix to Present at the Guggenheim 6th Annual Biotechnology Conference

PARIS and CAMBRIDGE, Mass., Jan. 29, 2024 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext : NANO NASDAQ: NBTX the ''Company''), a late-clinical stage biotechnology company pioneering physics-based...

Nanobiotix Announces Achievement of $20M Development Milestone Payment Related to Ongoing Global Phase 3 Head and Neck Cancer Study

Nanobiotix SA (NBTX, $7.4) entered Downtrend as Momentum indicator drops below 0 level on Jan 25, 2024

Nanobiotix SA is a late-stage biotechnology company, which engages in the development of therapeutic approaches to the treatment of cancer. Its technologies include NanoXray that improves the efficacy of radiation therapy against tumor cells. The company was founded by Laurent Lévy and Abdel Kader Boussaha on March 4, 2003 and is headquartered in Paris, France.

Volume	97.00
52-Wk High	$11.00
52-Wk Low	$4.55

NBTX Nanobiotix - ADR

About

Feed

News

Earnings

Fundamentals